GENEVA, June 12 -- GENZYME CORPORATION (450 Water StreetCambridge, Massachusetts 02141) filed a patent application (PCT/US2024/057416) for "METHODS FOR TREATING CD20-RELATED DISORDERS" on Nov 26, 2024. With publication no. WO/2025/117516, the details related to the patent application was published on Jun 05, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MOLONY, Cliona Marie (c/o Genzyme Corporation450 Water StreetCambridge, Massachusetts 02141)
Abstract:
Disclosed are methods of treating various disorders with anti-CD20 antibodies and fragments thereof.
For more information:https://p...